These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2439169)
1. Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry. Lane RF; Blaha CD Brain Res; 1987 Apr; 408(1-2):317-20. PubMed ID: 2439169 [TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Blaha CD; Lane RF Neurosci Lett; 1987 Jul; 78(2):199-204. PubMed ID: 2888060 [TBL] [Abstract][Full Text] [Related]
3. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Lane RF; Blaha CD Brain Res Bull; 1987 Jan; 18(1):135-8. PubMed ID: 3828839 [TBL] [Abstract][Full Text] [Related]
4. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity. Lai H; Carino MA; Sperry R; Horita A J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914 [No Abstract] [Full Text] [Related]
5. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum. de Belleroche JS; Neal MJ Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910 [TBL] [Abstract][Full Text] [Related]
6. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens. Compton DR; Johnson KM J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468 [TBL] [Abstract][Full Text] [Related]
7. Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study. Stamford JA; Kruk ZL; Millar J Br J Pharmacol; 1988 Jul; 94(3):924-32. PubMed ID: 2902896 [TBL] [Abstract][Full Text] [Related]
8. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats. Narumi S; Nagai Y; Saji Y; Nagawa Y Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169 [TBL] [Abstract][Full Text] [Related]
9. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. Moghaddam B; Bunney BS J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939 [TBL] [Abstract][Full Text] [Related]
10. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo. Ichikawa J; Meltzer HY Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112 [TBL] [Abstract][Full Text] [Related]
11. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens. Lane RF; Blaha CD; Phillips AG Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862 [TBL] [Abstract][Full Text] [Related]
12. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. Meltzer HY; Chai BL; Thompson PA; Yamamoto BK J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957 [TBL] [Abstract][Full Text] [Related]
13. Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross-validation using in vivo voltammetry and microdialysis. Blaha CD; Coury A; Fibiger HC; Phillips AG Neuroscience; 1990; 34(3):699-705. PubMed ID: 2352647 [TBL] [Abstract][Full Text] [Related]
14. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J; Meltzer HY Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042 [TBL] [Abstract][Full Text] [Related]
15. Acute administration of clozapine, thioridazine and metoclopramide increases extracellular DOPAC and decreases extracellular 5-HIAA, measured in the nucleus accumbens and striatum of the rat using in vivo voltammetry. Maidment NT; Marsden CA Neuropharmacology; 1987; 26(2-3):187-93. PubMed ID: 2438582 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry. Lane RF; Blaha CD; Rivet JM Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047 [TBL] [Abstract][Full Text] [Related]
17. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment. Ichikawa J; Meltzer HY Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571 [TBL] [Abstract][Full Text] [Related]
18. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Hernandez L; Hoebel BG Brain Res Bull; 1989 Apr; 22(4):763-9. PubMed ID: 2736403 [TBL] [Abstract][Full Text] [Related]
19. Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat. Iyengar S; Kim HS; Wood PL Neurosci Lett; 1987 Jun; 77(2):226-30. PubMed ID: 3601233 [TBL] [Abstract][Full Text] [Related]
20. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]